Instrument Inactif

Communiqués Medipharm Labs Corp Toronto S.E.

Actions

Cours en clôture Toronto S.E. Autres places de cotation
- ^CAD	-

26/06	Transcript : MediPharm Labs Corp. - Shareholder/Analyst Call
20/06	MediPharm Labs acquiert les droits pour les produits avancés à base de cannabis médical de Remidose Aerosols	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders	26/06	PR
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders	26/06	AQ
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols	20/06	AQ
MediPharm Labs Reports First Quarter Results	15/05	AQ
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results	08/05	AQ
MediPharm Labs Provides Conference Call Recording Details	27/03	AQ
MediPharm Labs Reports Fourth Quarter and Full Year Results	27/03	AQ
MediPharm Labs Provides Update on German Cannabis Legalization	25/03	AQ
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results	22/03	AQ
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority	07/02	AQ
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program	22/12	PR
MediPharm Labs Reports Third Quarter Results	14/11	AQ
MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results	08/11	AQ
MediPharm Labs Update on $9M Settlement Agreement, All Tilray Shares Sold and Converted to Cash	26/10/23	AQ
MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash	25/10/23	AQ
MediPharm Labs Settles an Outstanding Claim for $9M	02/10/23	AQ
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market	27/09/23	AQ
MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement	20/09/23	AQ
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million	05/09/23	AQ
MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients	31/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Medipharm Labs Corp Toronto S.E.

Actions

Communiqués

Filtres